| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director
1 company
Lewis Joel is a President And CEO at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 667 | $4.82 | $3,214.07 | +1.0% | |
| Feb 7, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 1,000 | $4.48 | $4,484.10 | +1.6% | |
| Jan 29, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 1,000 | $4.81 | $4,805.00 | +1.6% |